Cancer test study pulled before it even started
NCT ID NCT05296135
First seen Feb 28, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This study planned to check if a special test, called OncoPrism-HNSCC, could predict how well immunotherapy would work in people with head and neck cancer. Researchers wanted to compare test results with actual treatment outcomes. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Curebase
San Francisco, California, 94131, United States
Conditions
Explore the condition pages connected to this study.